164 related articles for article (PubMed ID: 32815445)
21. Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.
Ayaz NA; Tanatar A; Karadağ ŞG; Çakan M; Keskindemirci G; Sönmez HE
Rheumatol Int; 2021 Jan; 41(1):113-120. PubMed ID: 32347339
[TBL] [Abstract][Full Text] [Related]
22. Semen analysis in adolescents with familial Mediterranean fever.
Kaya Aksoy G; Koyun M; Usta MF; Çomak E; Akman S
J Pediatr Urol; 2019 Aug; 15(4):342.e1-342.e7. PubMed ID: 31036478
[TBL] [Abstract][Full Text] [Related]
23. Ankylosing Spondylitis Among Familial Mediterranean Fever Patients.
Merashli M; Noureldine MHA; Tfayli Y; Jawad A; Uthman I
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):148-154. PubMed ID: 28982344
[TBL] [Abstract][Full Text] [Related]
24. The anemia of familial Mediterranean fever disease.
Celkan T; Celik M; Kasapçopur O; Ozkan A; Apak H; Ocak S; Arisoy N; Yildiz I
Pediatr Hematol Oncol; 2005 Dec; 22(8):657-65. PubMed ID: 16251171
[TBL] [Abstract][Full Text] [Related]
25. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
27. Familial Mediterranean fever-associated infertility and underlying factors.
Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A
Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094
[TBL] [Abstract][Full Text] [Related]
28. The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis.
Ugan Y; Korkmaz H; Dogru A; Koca YS; Balkarlı A; Aylak F; Tunc SE
Clin Rheumatol; 2016 Jul; 35(7):1669-72. PubMed ID: 26873102
[TBL] [Abstract][Full Text] [Related]
29. Clues for inflammatory diseases in the differential diagnosis of a child with sacroiliitis.
Karagöl C; Güngörer V; Ekici Tekin Z; Çelikel E; Aydın F; Kurt T; Tekgöz N; Sezer M; Coşkun S; Kaplan MM; Öner N; Polat MG; Tiftik M; Tıgrak S; Dereci S; Hızlı Ş; Acar BÇ
Pediatr Int; 2023 Jan; 65(1):e15504. PubMed ID: 36780151
[TBL] [Abstract][Full Text] [Related]
30. Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?
Ozcan G; Cayci S; Celikel Acar B; Basaran O; Aydin F; Elhan AH; Cakar N
Int J Clin Pract; 2021 Nov; 75(11):e14678. PubMed ID: 34328662
[TBL] [Abstract][Full Text] [Related]
31. Seronegative spondyloarthropathy of familial Mediterranean fever.
Incel NA; Saraçoğlu M; Erdem HR
Rheumatol Int; 2003 Jan; 23(1):41-3. PubMed ID: 12611376
[TBL] [Abstract][Full Text] [Related]
32. Seronegative spondyloarthropathy in familial Mediterranean fever.
Langevitz P; Livneh A; Zemer D; Shemer J; Pras M
Semin Arthritis Rheum; 1997 Oct; 27(2):67-72. PubMed ID: 9355205
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the international severity score for FMF (ISSF) scores in Turkish children diagnosed with FMF: a single-center experience.
Özdemir FMA; Gülez N; Makay B
Clin Rheumatol; 2021 Aug; 40(8):3219-3225. PubMed ID: 33619627
[TBL] [Abstract][Full Text] [Related]
34. Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever.
Adrovic A; Yıldız M; Kanber M; Ulkersoy I; Gucuyener N; Koker O; Sahin S; Barut K; Kasapcopur O
Rheumatol Int; 2020 Jan; 40(1):91-96. PubMed ID: 31346686
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
[TBL] [Abstract][Full Text] [Related]
36. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?
Sönmez HE; Esmeray P; Batu ED; Arıcı ZS; Demir S; Sağ E; Özen S; Bilginer Y
Rheumatol Int; 2019 Jan; 39(1):83-87. PubMed ID: 30088045
[TBL] [Abstract][Full Text] [Related]
37. Hip involvement in patients with familial Mediterranean fever. A review of ten cases.
Younes M; Kahn MF; Meyer O
Joint Bone Spine; 2002 Dec; 69(6):560-5. PubMed ID: 12537263
[TBL] [Abstract][Full Text] [Related]
38. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
[TBL] [Abstract][Full Text] [Related]
39. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.
Balaban B; Yasar E; Ozgul A; Dincer K; Kalyon TA
Rheumatol Int; 2005 Oct; 25(8):641-4. PubMed ID: 15711787
[TBL] [Abstract][Full Text] [Related]
40. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
